REFERENCES
1. Nedkoff L, Briffa T, Zemedikun D, Herrington S, Wright FL. Global trends in atherosclerotic cardiovascular disease. Clin Ther. 2023;45:1087-91.
2. Labrecque Langlais É, Corbin D, Tastet O, et al. Evaluation of stenoses using AI video models applied to coronary angiography. NPJ Digit Med. 2024;7:138.
3. Abdelrahman KM, Chen MY, Dey AK, et al. Coronary computed tomography angiography from clinical uses to emerging technologies: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76:1226-43.
4. Dzaye O, Razavi AC, Blaha MJ, Mortensen MB. Evaluation of coronary stenosis versus plaque burden for atherosclerotic cardiovascular disease risk assessment and management. Curr Opin Cardiol. 2021;36:769-75.
5. Veelen A, van der Sangen NMR, Henriques JPS, Claessen BEPM. Identification and treatment of the vulnerable coronary plaque. Rev Cardiovasc Med. 2022;23:39.
6. Chen Q, Pan T, Wang YN, et al. A coronary CT angiography radiomics model to identify vulnerable plaque and predict cardiovascular events. Radiology. 2023;307:e221693.
7. Tearney GJ, Regar E, Akasaka T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the international working group for intravascular optical coherence tomography standardization and validation. J Am Coll Cardiol. 2012;59:1058-72.
8. Radu MD, Yamaji K, García-García HM, et al. Variability in the measurement of minimum fibrous cap thickness and reproducibility of fibroatheroma classification by optical coherence tomography using manual versus semi-automatic assessment. EuroIntervention. 2016;12:e987-97.
9. Huisman J, Egede R, Rdzanek A, et al. Multicenter assessment of the reproducibility of volumetric radiofrequency-based intravascular ultrasound measurements in coronary lesions that were consecutively stented. Int J Cardiovasc Imaging. 2012;28:1867-78.
10. Klüner LV, Chan K, Antoniades C. Using artificial intelligence to study atherosclerosis from computed tomography imaging: a state-of-the-art review of the current literature. Atherosclerosis. 2024;398:117580.
11. Xu P, Liu T, Zhou F, et al. Artificial intelligence in coronary computed tomography angiography. Medicine Plus. 2024;1:100001.
12. Rinehart S, Raible SJ, Ng N, et al. Utility of artificial intelligence plaque quantification: results of the DECODE study. J Soc Cardiovasc Angiogr Interv. 2024;3:101296.
13. Cho GW, Anderson L, Quesada CG, et al. Serial analysis of coronary artery disease progression by artificial intelligence assisted coronary computed tomography angiography: early clinical experience. BMC Cardiovasc Disord. 2022;22:506.
14. Chandramohan N, Hinton J, O’Kane P, Johnson TW. Artificial intelligence for the interventional cardiologist: powering and enabling OCT image interpretation. Interv Cardiol. 2024;19:e03.
15. Zhang C, Guo X, Guo X, et al. Machine learning model comparison for automatic segmentation of intracoronary optical coherence tomography and plaque cap thickness quantification. Comput Model Eng Sci. 2020;123:631-46.
16. Nurmohamed NS, Bom MJ, Jukema RA, et al. AI-guided quantitative plaque staging predicts long-term cardiovascular outcomes in patients at risk for atherosclerotic CVD. JACC Cardiovasc Imaging. 2024;17:269-80.
17. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary calcium score and cardiovascular risk. J Am Coll Cardiol. 2018;72:434-47.
18. Criqui MH, Denenberg JO, Ix JH, et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA. 2014;311:271-8.
19. Muzammil MA, Javid S, Afridi AK, et al. Artificial intelligence-enhanced electrocardiography for accurate diagnosis and management of cardiovascular diseases. J Electrocardiol. 2024;83:30-40.
20. Feuchtner GM, Lacaita PG, Bax JJ, et al. AI-Quantitative CT coronary plaque features associate with a higher relative risk in women: CONFIRM2 registry. Circ Cardiovasc Imaging. 2025;18:e018235.
21. Williams MC, Kwiecinski J, Doris M, et al. Low-attenuation noncalcified plaque on CCTA predicts myocardial infarction: results from the multicenter SCOT-HEART trial (Scottish computed tomography of the HEART). Circulation. 2020;141:1452-62.
22. Kim Y, Yoon HJ, Suh J, et al; FLASH Trial Investigators. Artificial intelligence-based fully automated quantitative coronary angiography vs optical coherence tomography-guided PCI: The FLASH Trial. JACC Cardiovasc Interv. 2025;18:187-97.
23. Rosenbacke R, Melhus Å, McKee M, Stuckler D. How Explainable artificial intelligence can increase or decrease clinicians’ trust in AI applications in health care: systematic review. JMIR AI. 2024;3:e53207.
24. Pinna A, Boi A, Mannelli L, et al. Machine learning for coronary plaque characterization: a multimodal review of OCT, IVUS, and CCTA. Diagnostics. 2025;15:1822.
25. Tejani AS, Cook TS, Hussain M, Sippel Schmidt T, O’Donnell KP. Integrating and adopting AI in the radiology workflow: a primer for standards and integrating the healthcare enterprise (IHE) profiles. Radiology. 2024;311:e232653.
26. Dobrolińska MM, Gąsior PM, Pociask E, et al. Performance of integrated near-infrared spectroscopy and intravascular Ultrasound (NIRS-IVUS) system against quantitative flow ratio (QFR). Diagnostics. 2021;11:1148.
27. Wikimedia Commons. CCTA CAD-RADS 4a.png. Available from: https://commons.wikimedia.org/wiki/File:CCTA_CAD-RADS_4a.png [Last accessed on 15 Sep 2025].
28. Viscusi MM, La Porta Y, Migliaro G, et al. Current applications and new perspectives in optical coherence tomography (OCT) coronary atherosclerotic plaque assessment: from PCI optimization to pharmacological treatment guidance. Photonics. 2023;10:158.
29. Lin A, Manral N, McElhinney P, et al. Deep learning-enabled coronary CT angiography for plaque and stenosis quantification and cardiac risk prediction: an international multicentre study. Lancet Digit Health. 2022;4:e256-65.
30. Choudhary G, Atalay MK, Ritter N, et al. Interobserver reliability in the assessment of coronary stenoses by multidetector computed tomography. J Comput Assist Tomogr. 2011;35:126-34.
31. Zhuang B, Wang S, Zhao S, Lu M. Computed tomography angiography-derived fractional flow reserve (CT-FFR) for the detection of myocardial ischemia with invasive fractional flow reserve as reference: systematic review and meta-analysis. Eur Radiol. 2020;30:712-25.
32. Lipkin I, Telluri A, Kim Y, et al. Coronary CTA With AI-QCT interpretation: comparison with myocardial perfusion imaging for detection of obstructive stenosis using invasive angiography as reference standard. AJR Am J Roentgenol. 2022;219:407-19.
33. Nurmohamed NS, Danad I, Jukema RA, et al; CREDENCE and PACIFIC-1 Investigators. Development and validation of a quantitative coronary CT angiography model for diagnosis of vessel-specific coronary ischemia. JACC Cardiovasc Imaging. 2024;17:894-906.
34. Maclean E, Cronshaw R, Newby DE, Nicol E, Williams MC. Prognostic utility of semi-quantitative coronary computed tomography angiography scores in the SCOT-HEART trial. J Cardiovasc Comput Tomogr. 2023;17:393-400.
35. Johnson KM, Johnson HE, Zhao Y, Dowe DA, Staib LH. Scoring of coronary artery disease characteristics on coronary CT angiograms by using machine learning. Radiology. 2019;292:354-62.
36. Abbott. UltreonTM 1.0 software: experience the power of automation. Available from: https://www.cardiovascular.abbott/int/en/hcp/products/percutaneous-coronary-intervention/intravascular-imaging/ultreon-software/ultreon-1-0.html [Last accessed on 15 Sep 2025].
37. Boston Scientific. AVVIGOTM+ Multi-Modality Guidance System. Available from: https://www.bostonscientific.com/en-US/products/ffr-ivus-systems/avvigo-guidance-system.html [Last accessed on 15 Sep 2025].
38. Galo J, Chaturvedi A, Al-Qaraghuli A, et al. Machine learning in intravascular ultrasound: validating automated lesion assessment for complex coronary interventions. Catheter Cardiovasc Interv. 2025;105:1320-8.
39. In Kim Y, Roh JH, Kweon J, et al. Artificial intelligence-based quantitative coronary angiography of major vessels using deep-learning. Int J Cardiol. 2024;405:131945.
40. HeartFlow. Heartflow introduces next generation interactive plaque analysis platform to assess patient risk in suspected coronary artery disease. Available from: https://www.heartflow.com/press-release/Heartflow-plaque-interactive/ [Last accessed on 15 Sep 2025].
41. Cleerly. Not all plaque analysis software are the same: roviding multi-modality imaging decision support. Available from: https://cleerlyhealth.com/plaque-analysis [Last accessed on 15 Sep 2025].
42. Siemens Healthineers. AI-Rad Companion: providing multi-modality imaging decision support. Available from: https://www.siemens-healthineers.com/en-us/digital-health-solutions/ai-rad-companion [Last accessed on 15 Sep 2025].
43. Kay FU, Canan A, Kukkar V, et al. Diagnostic accuracy of on-premise automated coronary CT Angiography analysis based on coronary artery disease reporting and data system 2.0. Radiology. 2025;315:e242087.
44. NANOX. Nanox receives FDA clearance for HealthCCSng V2.0, upgraded version of advanced AI cardiac solution empowering physicians in assessment of coronary artery calcium. Available from: https://investors.nanox.vision/news-releases/news-release-details/nanox-receives-fda-clearance-healthccsng-v20-upgraded-version [Last accessed on 15 Sep 2025].
